Clinical Trial Update: Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM) [Phase 1]

View source ↗

Summary

Phase 1 trial PRISM investigates personalized radiotherapy for extensive-stage small cell lung cancer with brain metastases; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Small Cell Lung Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Small Cell Lung Cancer Extensive Stage, Brain Metastases | Phase 1 | Status: RECRUITING